leisure time -WSS

leisure time

author：knowledge 2025-10-02 01:07:23 - browse：22389

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Cancer drug shortages should be causing more outrage

focus

WSS

Where does female orgasm come from? Scientists think they know

Cancer drug shortages should be causing more outrage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

4 missing after record

BioMarin wins approval for gene therapy to treat hemophilia A

Psychedelics group wrestles with new pharma identity

Wikipedia

leisure time

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Wildfire smoke exposes gaps in outdoor worker protections

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How a key Senate committee is planning to regulate PBMs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Alkermes shareholders re

Anesthesiologist group: stop taking Ozempic before surgery

Duchenne breakthrough therapy leaves behind pioneering families

Medical records are filled with copy

In Memoriam: Notable people who died in 2023

explore

PrEP can help anyone prevent HIV. Why do so few people take it?

New air purifier tech could be key to improving indoor air quality

Peter Hotez and the public health issue of online harassment

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Novartis develops a rapidly manufactured CAR

Hepatitis C has a cure — but many Americans still lack access to it

knowledge

explore

focus

explore